Sato Yuhki, Katagiri Fumihiko, Inoue Shin, Itoh Hiroki, Takeyama Masaharu
Department of Clinical Pharmacy, Oita University Hospital, Oita, Japan.
Biol Pharm Bull. 2004 Nov;27(11):1875-7. doi: 10.1248/bpb.27.1875.
Sensory afferent neurons in the gastrointestinal mucosa regulate neuropeptides [calcitonin gene-related peptide (CGRP), substance P, etc.], which play various physiologic roles and are gastroprotective. To determine whether the pharmacologic effects of Dai-kenchu-to (DKCT) on the gastrointestine are due to changes in gastrointestinal mucosa regulatory peptide levels, we examined the effects of the DKCT on the levels of CGRP-like immunoreactive substances (IS) and substance P-IS in plasma taken from five healthy subjects. A single oral administration of DKCT 7.5 g caused significant increases in plasma CGRP-IS at 40 min, and in substance P-IS levels at 20 and 60 min, compared with a placebo group. The present study may indicate that the pharmacologic action of DKCT is closely related to changes in CGRP- and substance P-IS levels.
胃肠道黏膜中的感觉传入神经元调节神经肽(降钙素基因相关肽、P物质等),这些神经肽发挥着各种生理作用且具有胃保护作用。为确定大建中汤(DKCT)对胃肠道的药理作用是否归因于胃肠道黏膜调节肽水平的变化,我们检测了DKCT对5名健康受试者血浆中降钙素基因相关肽样免疫反应物质(IS)和P物质-IS水平的影响。与安慰剂组相比,单次口服7.5 g DKCT可使血浆降钙素基因相关肽-IS在40分钟时显著升高,使P物质-IS水平在20分钟和60分钟时显著升高。本研究可能表明,DKCT的药理作用与降钙素基因相关肽和P物质-IS水平的变化密切相关。